CardioNet (BEAT) Announces Humana Upgrades CardioNet System to Covered Benefit Status
More News related to BEAT
- CardioNet, Inc. to Present at Lazard 5th Annual Healthcare Conference
- CardioNet System Receives Category I CPT Codes and Reimbursement Rates
- Citi Upgrades CardioNet (BEAT) to Buy
- CardioNet (BEAT) Tops Q3 EPS by 1c, Reaffirms FY Revenues
- CardioNet, Inc. Reports Strong Third Quarter 2008 Results
More News related to Corporate News
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
CardioNet, Inc. (NASDAQ: BEAT) announced that Humana, a large healthcare third-party payor, upgraded the CardioNet System to a "covered benefit" status. Previously, the CardioNet System was categorized by Humana as "experimental-investigational."
Humana's 11 million covered members will have access to coverage for prescriptions for the CardioNet System effective September 1, 2008, subject to normal insurance policy guidelines. Humana's decision was impacted by the peer-reviewed results of a 300-patient randomized clinical trial published in the March 2007 issue of the Journal of Cardiovascular Electrophysiology, demonstrating that the CardioNet System provided a significantly higher diagnostic yield compared to traditional loop event monitoring for patients who had non-diagnostic Holter monitoring.
CardioNet, Inc. is a leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health.
Related Categories
Corporate NewsStocks Mentioned
-0.60Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
